Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Price Crosses Below 200 Day Moving Average – What’s Next?

Shares of Ono Pharmaceutical Co. (OTCMKTS:OPHLF) passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $14.87 and traded as low as $14.10. Ono Pharmaceutical shares last traded at $14.10, with a volume of 1,000 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research lowered Ono Pharmaceutical from a “strong-buy” rating to a “hold” rating in a report on Friday, September 4th. One research analyst has rated the stock with a Hold rating. According to MarketBeat, the company currently has an average rating of “Hold”.

Ono Pharmaceutical Price Performance

The stock’s 50 day moving average price is $15.17 and its two-hundred day moving average price is $14.87. The firm has a market capitalization of $6.63 billion, a price-to-earnings ratio of 13.43 and a beta of 0.38. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.28 and a quick ratio of 2.86.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd. is a Japan-based research-driven pharmaceutical company focused on discovering, developing and commercializing prescription medicines. Its primary therapeutic areas include oncology, immunology, neurology and other specialty-care fields. The company develops medicines internally and also works with research institutions and global pharmaceutical partners.

Ono is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used in the treatment of multiple types of cancer.